Groundbreaking trial tests malaria vaccine to protect moms and babies
NCT ID NCT05652504
Summary
This study aims to test the safety of an experimental malaria vaccine (PfSPZ) in pregnant women. It involves 400 healthy pregnant participants in Mali who will receive either the vaccine or a placebo injection. Researchers will closely monitor the women and their babies for over a year to check for any side effects and see if the vaccine might help prevent malaria infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ou(SqrRoot)(Copyright)less(SqrRoot)(Copyright)bougou, Health Research Center
Ou(SqrRoot)(Copyright)less(SqrRoot)(Copyright)bougou, Mali
Conditions
Explore the condition pages connected to this study.